A combination stylet device for use in guiding an endotracheal tube during an intubation procedure includes an elongated hollow sleeve having a fitting at one end configured for mating with a syringe and a nozzle at the second end for generating a fine spray of a liquid forward from the second end. An elongated bendable guiding stylet is disposed coaxially within the sleeve to define a channel through which pressurized liquid is conducted from the fitting to the nozzle. The sleeve is inserted into the endotracheal tube during intubation to guide the insertion and to allow for administration a medication from the end of the endotracheal tube.

Dispensing assembly, comprising a fluid product dispenser, such as a nasal dispenser, wherein the fluid product dispenser comprises a reservoir (10) provided with a bottom (11), a dispensing member (20), such as a pump or a valve, mounted on the reservoir (10), and a dispensing head (30) incorporating a dispensing orifice (31), the dispensing assembly comprising a lateral actuation device comprising a body (1) and a lateral actuation element (40) mounted so as to pivot on the body (1) about a pivot axis (45) between a rest position and an actuation position, the actuation element (40) comprising a bearing part (41), which is pressed by the user during actuation and a pushing part (42) designed to cooperate with the fluid product dispenser to effect the actuation thereof, the pivot axis (45) being arranged between the bearing part (41) and the pushing part (42), the lateral actuation member (40) having an S or inverted S shape, the bearing part (41) being arranged near the dispensing head (30) and the pushing part (42) being arranged under the bottom (11) of the reservoir (10).

In general, drug administration devices configured to communicate with networks and external devices are provided. In an exemplary embodiment, a drug administration device is configured to adjust an operational parameter of the drug administration device based on a data packet formed from drug administration data ancillary data received from networks and/or external devices. In another example embodiment, a drug administration device is configured to scan for and establish communications with at least one external device. In another example embodiment, a method includes assessing whether to update a control program on a drug administration device from a network or external device. In another example embodiment, a system includes a first drug administration device configured to communicate with a second drug administration device to optimize a drug treatment.

Liquid drug cartridges and an associated inhaler are used to deliver one more separate doses of an aerosolized liquid drug. A cartridge includes a container for storing the liquid drug, an end cap having an ejection opening, a filter element, and a piston that is repositionable relative to the container to selectively eject a volume of liquid drug from the ejection opening. The filter element filters the liquid drug prior to ejection from the ejection opening. The liquid drug cartridge can be coupled with an inhaler that includes an aerosol generator. The aerosol generator includes a vibratable membrane onto which the liquid drug is ejected. The liquid drug is aerosolized by the vibration of the membrane for inhalation by a user.

Embodiments relate to an intranasal drug delivery device, system, and process. The drug delivery device can have a compliant/flexible soft nib. The drug delivery device can have an actuator and shot chamber. The drug delivery device can have a non-air interface mechanically pressurized fluid reservoir. The drug delivery device can have a facial or device recognition application to prevent intentional or unintentional misuse.

An ultrasonic medicine application device that strongly promotes medicine absorption, having a housing, a control panel and a circuit board inside the housing, a medicine supply mechanism and an ultrasonic massage mechanism on a bottom surface of the housing. The ultrasonic massage mechanism has a base panel having massage projections, and also an electrical ultrasonic vibration element, which drives the projections make high frequency ultrasonic vibration. The medicine supply mechanism is positioned between the ultrasonic massage mechanism and the circuit board, and is configured to supply medicine towards the ultrasonic massage mechanism.

The invention relates to the field of inhalation devices for liquids. In particular, the invention relates to an inhalation device having improved flow characteristics. A inhalation device for medically active liquids (F) for generation of an aerosol comprises a housing (1), inside this housing (1) a reservoir (2) for storing a liquid (F), a pumping device with a hollow cylinder (9) providing a pumping chamber (3) for the generation of a pressure inside said pumping chamber (3), wherein the pumping chamber is fluidically connected with the reservoir (2) via an inlet check valve (4) which blocks in direction of the reservoir (2), a riser pipe (5) which can be received with at least one reservoir-facing, interior end (5A) in said hollow cylinder (9), and a nozzle (6) which is connected liquid-tight to an exterior end (5B) of the riser pipe (5), wherein the volume of the pumping chamber (3) is changeable by means of relative motion of the cylinder (9) to the riser pipe (5), and is characterised in that the riser pipe (5) is immobile and firmly attached to the housing (1) and to the nozzle (6), whereas the hollow cylinder (9) is moveable relative to the housing (1) and to the nozzle (6). The invention also discloses a method for the generation of an aerosol of a medically active liquid (F) by means of an inhalation device.

The spray application device with angled tip may comprise an applicator and an activator, where the applicator has a nozzle for delivery of a sprayable material. The spray application device may store a medication and may dispense the medication as an aerosol mist. The medication applicator may be adapted to dispense the medication through a nostril of a user directed at the posterior nasal cavity. The spray application device may be operable to release the medication in multiple doses of predetermined volume. The spray application device may be adapted for the user to self-administer the medication while positioned in any preferred physical position. A nozzle with a compliant nozzle shroud, an angled tip, and anatomically optimized nozzle geometry may direct the medication to a precise location within the posterior nasal cavity of a user.

An atomizer is disclosed. The atomizer includes: a pump housing including an internal chamber extending in an axial direction of the pump housing and a mounting seat disposed at a first end of the pump housing and being in communication with the internal chamber; a seal disposed in the mounting seat, the seal including a sealing sleeve and a first bore in the sealing sleeve and coaxial with the internal chamber, and at least a part of the seal resting against a mounting surface of the mounting seat; a pressing member at least partially disposed within the mounting seat and resting against the seal to press and keep the seal in the mounting seat, the pressing member including a second bore coaxial with the internal chamber; and a plunger, a first end of the plunger being disposed within the internal chamber of the pump housing through the second bore of the pressing member and the first bore of the seal, and the first end of the plunger being capable of reciprocating in the internal chamber to pump fluid in or out of the internal chamber; wherein the pump housing, the pressing member and the plunger together define a sealing cavity to accommodate the seal.

Disclosed are: a system comprising a gas circulation device capable of circulating hyperthermic gas in the peritoneal cavity and a temperature control device; and a system comprising a drug spray device for effectively spraying a drug in the peritoneal cavity together with gas. The systems of the present invention are used as systems for hyperthermic intraperitoneal chemotherapy and can maximize the anticancer therapy effect by more effectively delivering a small amount of an anticancer drug to cancer cells while maintaining the temperature of gas in the peritoneal cavity at a predetermined temperature.